A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies | Advances in Therapy
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
iLite® CD20 (+) Target
Anti-mouse CD20 | 18B12-derived | InvivoGen
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
An Overview of CD20 Monoclonal Antibodies Drugs- CUSABIO
Protéine CD20 pleine longueur exprimée HEK293 avec Nanodisc / DDM / VLP - ACROBiosystems
CD20 — Wikipédia
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
AntiCD20+ Agents - Practical Neurology
Evolution of anti-CD20 monoclonal antibody therapeutics in oncology. - Abstract - Europe PMC
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
![Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com](https://cdn.antibodies.com/image/catalog/85/A85690_157.jpg?profile=product_top "Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com")
Anti-CD20 Anticorps [2H7] (APC) (A85690) | Antibodies.com
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Frontiers | Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Lymphatics | Free Full-Text | A Review of Anti-CD20 Antibodies in the Management of B-Cell Lymphomas
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
Comparison of commercially available anti-CD20 antibodies | Download Table
Antibody drug development: Targeting CD20 and CD3
Full article: Anti-CD20 treatment for B-cell malignancies: current status and future directions
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Characteristics of selected anti-CD20 monoclonal antibodies | Download Table
